Characteristics | CCM (n = 125) | EAPM (n = 132) | P valuea |
---|---|---|---|
Age (year) | 58.4 (11.0) | 54.1 (12.4) | 0.003 |
BMI (kg/m2) | 22.9 (3.9) | 23.3 (4.3) | 0.358 |
Margin positive (≤ 5 mm) and Boost | 20.0% | 29.6% | 0.077 |
Chemotherapy | 38.4% | 47.7% | 0.131 |
Hormone therapy | 72.0% | 70.5% | 0.784 |
Tumor locationb | |||
A | 20.0% | 22.0% | 0.907 |
B | 16.0% | 16.7% | |
C | 46.4% | 47.0% | |
D | 17.6% | 14.4% | |
T factorc | |||
0 | 4.0% | 5.3% | 0.081 |
1 | 86.4% | 75.8% | |
2 | 9.6% | 18.9% | |
N factorc | |||
0 | 79.2% | 90.9% | 0.008 |
1 | 20.8% | 9.1% | |
Stagec | |||
0 | 3.2% | 5.3% | 0.698 |
1 | 68.0% | 67.4% | |
2a | 28.8% | 27.3% | |
Operation time (min) | 62.0 (25.4) | 79.8 (23.5) | < 0.001 |
Operative bleeding (mL) | 52.0 (47.5) | 98.6 (84.1) | < 0.001 |